Allelotype analysis of 2',3'-dideoxycytidine- and 1,3-butadiene-induced lymphomas in B6C3F1 mice

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3338-3343

  Zhuang, Shi Mei ^a   Eklund, Lena K ^a   Cochran, Charles ^b   Rao, Ghanta N ^b   Wiseman, Roger W ^b   Söderkvist, Peter ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ZALCITABINE;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 2; CHROMOSOME 4; CHROMOSOME 9P; GENE CLUSTER; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ALLELES; ANIMALS; BUTADIENES; CHROMOSOME MAPPING; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HETEROZYGOTE; LYMPHOMA; MICE; MICE, INBRED STRAINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SEQUENCE DELETION; ZALCITABINE;

EID: 0029957773     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Levine, A. J The tumor suppressor genes Annu. Rev. Biochem., 62: 623-651, 1993.
2. Seizinger, B R., Klinger, H P., Junien, C., Nakamura, Y., Le Beau, M., Cavenee, W , Emanuel, B., Ponder, B., Naylor, S., Mitelman, F , Louis, D., Newsham, I., Decker, J., Kaelbling, M , Henry, I., and Deimling, A Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet., 58: 1080-1096, 1991.
3. Vogelstein, B., Fearon, E. R., Kern, S. E , Hamilton, S R., Preisinger, A C., Nakamura, Y., and White, R Allelotype of colorectal carcinomas Science (Washington DC), 244: 207-211, 1989
4. Dietrich, W F., Miller, J. C., Steen, R. G , Merchant, M , Damron, D , Nahf, R , Gross, A., Joyce, D. C , Wessel, M , Dredge, R D., Marquis, A , Stein, L D., Goodman, N , Page, D C., and Landers, E S. A genetic map of the mouse with 4,006 simple sequence length polymorphisms. Nat Genet., 7: 220-240, 1994
5. Gyapay, G , Monsette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S , Bernardi, G., Lathrop, M , and Weissenbach, J. The 1993-94 Généthon human genetic linkage map. Nat Genet., 7: 246-339, 1994.
6. Wiseman, R. W , Cochran, C., Dietrich, W., Lander E S., and Söderkvist, P. Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice, frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes. Proc Natl. Acad. Sci. USA, 91: 3759-3763, 1994
7. Devesa, S. S., and Fears, T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res , 52 (Suppl.): 5432s-5440s, 1992
8. Pearce, N , and Bethwaite, P. Increasing incidence of non-Hodgkin's lymphoma, occupational and environmental factors. Cancer Res., 52 (Suppl.): 5496s-5500s, 1992.
9. Matanoski, G. M , Santos-Burgoa, C , and Schwartz, L. Mortality of a cohort of workers in the styrene-butadiene polymer (SBR) manufacturing industry 1943-1982. Environ. Health Perspect., 86: 107-117, 1990.
10. Divine, B J An update on mortality among workers at a butadiene facility- preliminary results. Environ. Health Perspect , 86: 119-128, 1990
11. IARC. 1,3-Butadiene. IARC Monogr., 54: 237-285, 1992
12. Melnick, R. L., Huff, J , Chou, B. J., and Miller, R. A Carcinogenicity of 1,3-butadiene in C57BL/6 X C3H F1 mice at low exposure concentrations. Cancer Res., 50: 6592-6599, 1990.
13. Sanders, V M., Elwell, M. R., Heath, J. E., Collins, B. J., Dunnick, J. K., Rao, G. N., Prejean, D , Lindamood, C., III, and Irwin, R. D Induction of thymic lymphoma in mice administered the dideoxynucleoside ddC Fundam Appl. Toxicol , 27: 263-269, 1995.
14. Jackson, D. P , Hayden, J D., and Quirke, P. Extration of nucleic acid from fresh and archival materials. In: M J McPherson, P. Quirke, and G. R. Taylor (eds.), PCR: A Practical Approach, Ed. 1., pp. 29-32. Oxford, United Kingdom: Oxford University Press, 1992.
15. Buchberg, A. M , Buchwalter, M S , and Camper, S. A. Mouse chromosome 11. Mamm Genome, 3 (Suppl ): S162-S181, 1992
16. Roulston, D , Espinosa, R., III, Stoffel, M., Bell, G. I , and Le Beau, M M. Molecular genetics of myeloid leukemia: identification of the commonly deleted segment of chromosome 20 Blood, 82: 3424-3429, 1993.
17. Asimakopoulos, F. A., White, N. J., Nacheva, E., and Green, A. R Molecular analysis of chromosome 20q deletion associated with myeloproliferative disorders and myelodysplastic syndromes. Blood, 84: 3086-3094, 1994.
18. Rhee, S. G , Suh, P. G , Ryu, S. H., and Lee, S Y. Studies of inositol phospholipid-specific phospholipase C. Science (Washington DC), 244: 546-550, 1989
19. Merino, A., Madden, K R., Lane, W. S., Champoux, J. J., and Reinberg, D. DNA topoisomerase I is involved in both repression and activation of transcription. Nature (Lond.), 365: 227-232, 1993.
20. Helin, K , Harlow, E., and Fattaey. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol., 13: 6501-6508, 1993.
21. Bernards, R Cycling in Switzerland: cancer and the cell cycle. Trends Genet , 12: 158-159, 1996
22. Ewen, M. E., Xing, Y , Lawrence, J. B., and Livingston, D M Molecular cloning, chromosomal mapping, and expression of the cDNA for p107, a retinoblastoma gene product-related protein. Cell, 66: 1155-1164, 1991.
23. Faha, B , Ewen, M. E., Tsai, L-H , Livingston, D M., and Harlow, E. Interaction between human cyclin A and adenovirus E1A-associated p107 protein. Science (Washington DC), 255: 87-90, 1992.
24. Greenblatt, M. S , Bennett, W. P., Hollstein, M., and Harris, C. C Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 15: 4855-4878, 1994.
25. Murphy, S B., Raimondi, S C., Rivera, G. K., Crone, M., Dodge, R K., Behm, F. G., Pui, C-H., and Williams, D L Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood, 74: 409-415, 1989.
26. Diaz, M O , Rubin, C. M., Harden, A., Zieman, S., Larson, R. A., Le Beau, M. M , and Rowley, J D. Deletions of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med , 322: 77-82, 1990
27. Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L , Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M , Cho, K. R., Hedrick, L., Bova, G. S , Isaacs, W , Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumors Nat. Genet , 11: 210-212, 1995
28. Kamb, A., Gruis, N. A , Weaver-Feldhaus, J., Liu, Q , Harshman, K , Tavtigian, S. V., Stockert, E., Day, R. S , III, Johnson, B E , and Skolnick, M H. A cell cycle regulator potentially involved in genesis of many tumor types Science (Washington DC), 264: 436-440, 1994.
29. Nobori, T , Miura, K , Wu, D. J , Lois, A , Takabayashi, K , and Carson, D. A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers Nature (Lond), 368: 753-756, 1994.
30. INK4B/MTS2 in human leukemias and lymphomas. Cancer Res., 55: 1436-1440, 1995
31. INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. Blood, 84: 4038-4044, 1994
32. Stranks, G., Height, S. E., Mitchell, P., Jadayel, D , Yuille, M. A R., De Lord, C., Clutterbuck, R. D., Treleaven, J. G., Powles, R L., Nacheva, E , Oscier, D. G., Karpas, A , Lenoir, G M., Smith, S. D., Millar, J L , Catovsky, D , and Dyer, M. J S. Deletions and rearrangement of CDKN2 in lymphoma malignancy. Blood, 85: 893-901, 1995
33. Herzog, C R., Wiseman, R. W., and You, M. Deletion mapping of a putative tumor suppressor gene on chromosome 4 in mouse lung tumors. Cancer Res., 54: 4007-4010, 1994.
34. INK4b genes. Oncogene, 11: 635-645, 1995.
35. Herzog, C. R., Wang, Y., and You, M Allelic loss of distal chromosome 4 in mouse lung tumors localize to a putative tumor suppressor gene to a region homologous with human chromosome 1p36. Oncogene, 11: 1811-1815, 1995.
36. Nagat, H., Negrini, M., Carter, S L., Gillum, D R , Rosenberg, A L., Schwartz, G. F., and Croce, C M. Deletion and cloning of a common region of loss of heterozygosity at chromosome 1p in breast cancer. Cancer Res. 55: 1752-1757, 1995.
37. Bale, S. J., Dracopoli, N C., Tucker, M. A., Claek, W. H., Fraser, M. C , Stanger, B. Z., Green, P., Donis-Keller, H., Housman, D. E., and Greene, M. H. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N. Engl. J. Med., 320: 1367-1372, 1989.
38. Yeh, S-H., Chen, P-J., Chen H-L. Lai, M-Y , Wang, C-C., and Chen, D-S. Frequent genetic alterations at distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res , 54: 4188-4192, 1994.
39. Bardi, G., Pandis, N , Fenger, C., Kronborg, O., Somme, L., and Heim, S. H Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res , 53: 1895-1898, 1993.
40. Cheng, N C, Van Roy, N., Chan, A , Beitsma, M., Westerveld, A , Speleman, F., and Versteeg, R Deletion mapping in neuroblastoma cell lines suggest two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification. Oncogene, 10: 291-297, 1995.
41. Dietrich, W F., Lander, E. S , Smith, J S , Moster, A. R , Gould, K A., Luongo, C., Borenstein, N , and Dove, W. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse Cell, 75: 631-639, 1993.
42. Min-induced intestinal neoplasia Cell, 81: 957-966, 1995
43. Knudson, A. G., Jr Mutation and cancer statistical study of retinoblastoma. Proc Natl Acad. Sci. USA, 68: 820-823, 1971
44. Lathi, J. M , Valentine, M , Xiang, J , Jones, B., Amann, J., Grenet, J., Richmond, G., Look, A. T , and Kidd, V. J. Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma. Nat. Genet., 7: 371-375, 1994.
45. Young, J., Leggett, B., Ward, M., Thomas, L., Buttenshaw, R., Searle, J , and Chenevix-Trench, G. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas Oncogene, 8: 671-675, 1993.
46. Suzuki, T., Yokota, J., Mugishima, H., Okabe, I., Ookuni, M., Sugimura, T , and Terada, M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res, 49 1095-1098, 1989.
47. Chang, W. Y-H., Cairns, P., Schoenberg, M. P., Polascik, T. J., and Sidransky, D. Novel suppressor loci on chromosome 14q in primary bladder cancer Cancer Res., 55 3246-3249, 1995
48. Virgilio, L., Isobe, M , Narducci, M G., Carotenuto, P , Camerini, B., Kurosawa, N., Rushdi, A-A., Croce, C. M., and Russo, G. Chromosome walking on the TCL1 locus involved in T-cell neoplasia. Proc. Natl. Acad Sci. USA, 90: 9275-9279, 1993.
49. Solomon, E., Borrow, J., and Goddard, A D. Chromosome aberrations and cancers. Science (Washington DC), 254: 1153-1160, 1991.
50. Potter, M. Pathogenetic mechanisms in B-cell non-Hodgkin's lymphomas in humans. Cancer Res., 52 (Suppl.): 5522s-5528s, 1992.
51. INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22,q11) in an acute lymphoblastic leukemia of B-cel) type. Cancer Res., 56, 848-854, 1996